Mosca L, Rubenfire M, Mandel C, Rock C, Tarshis T, Tsai A, Pearson T
University of Michigan Preventive Cardiology Program, Department of Medicine, Ann Arbor 48106-0363, USA.
J Am Coll Cardiol. 1997 Aug;30(2):392-9. doi: 10.1016/s0735-1097(97)00188-5.
This study sought to determine the effect of antioxidant supplementation on the susceptibility of low density lipoprotein (LDL) to oxidation in patients with established cardiovascular disease (CVD).
Data are inconsistent regarding the role of antioxidant nutrients in the prevention of CVD.
The study design was a 12-week, double-blind, placebo-controlled clinical trial. Patients with CVD (n = 45) were randomized to 1) placebo control; 2) 400 IU of vitamin E, 500 mg of vitamin C, 12 mg of beta-carotene (mid-dose); or 3) 800 IU of vitamin E, 1,000 mg of vitamin C, 24 mg of beta-carotene (high dose) daily. Reduced susceptibility of LDL to oxidation was estimated by an increase in lag phase (minutes). Baseline and 6- and 12-week measurements of lipoproteins and lag phase were obtained. Plasma levels of antioxidants were measured at baseline and 12 weeks.
Concentrations of alpha-tocopherol, vitamin C and beta-carotene significantly increased in the mid- and high dose groups during the trial. Lag phase significantly increased from baseline (190.1 +/- 63.8 min [mean +/- SD]) to 12 weeks (391.1 +/- 153.0 min) in the high dose group (p < 0.01). A nonsignificant increase in lag phase in the mid-dose group was observed during the same time interval. A dose response was found for mean percent change from baseline to 12 weeks for lag phase for the placebo, mid- and high dose groups (p = 0.004 for trend).
A high dose combination of antioxidant nutrients reduces the susceptibility of LDL to oxidation in patients with CVD and may be useful in secondary prevention.
本研究旨在确定补充抗氧化剂对已确诊心血管疾病(CVD)患者低密度脂蛋白(LDL)氧化易感性的影响。
关于抗氧化营养素在预防心血管疾病中的作用,数据并不一致。
本研究设计为一项为期12周的双盲、安慰剂对照临床试验。患有心血管疾病的患者(n = 45)被随机分为1)安慰剂对照组;2)每日服用400国际单位维生素E、500毫克维生素C、12毫克β-胡萝卜素(中剂量);或3)每日服用800国际单位维生素E、1000毫克维生素C、24毫克β-胡萝卜素(高剂量)。通过滞后期(分钟)的增加来评估LDL氧化易感性的降低。获得脂蛋白和滞后期的基线值以及6周和12周的测量值。在基线和12周时测量血浆抗氧化剂水平。
在试验期间,中剂量和高剂量组的α-生育酚、维生素C和β-胡萝卜素浓度显著增加。高剂量组的滞后期从基线时的(190.1±63.8分钟[平均值±标准差])显著增加至12周时的(391.1±153.0分钟)(p < 0.01)。在相同时间间隔内,中剂量组的滞后期有不显著的增加。对于安慰剂组、中剂量组和高剂量组,从基线到12周滞后期的平均变化百分比存在剂量反应(趋势p = 0.004)。
高剂量的抗氧化营养素组合可降低CVD患者LDL的氧化易感性,可能对二级预防有用。